Front. Cell. Infect. Microbiol. Frontiers in Cellular and Infection Microbiology Front. Cell. Infect. Microbiol. 2235-2988 Frontiers Media S.A. 10.3389/fcimb.2021.550456 Cellular and Infection Microbiology Original Research Critically Ill vs. Non-Critically Ill Patients With COVID-19 Pneumonia: Clinical Features, Laboratory Findings, and Prediction Hong Wandong 1 * Chen Qin 2 Qian Songzan 2 Basharat Zarrin 3 Zimmer Vincent 4 5 Wang Yumin 6 Zippi Maddalena 7 Pan Jingye 8 * 1 Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 2 Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 3 Jamil-ur-Rahman Center for Genome Research, Dr. Panjwani Centre for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi-75270, Karachi, Pakistan 4 Department of Medicine II, Saarland University Medical Center, Saarland University, Homburg, Germany 5 Department of Medicine, Marienhausklinik St. Josef Kohlhof, Neunkirchen, Germany 6 Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China 7 Unit of Gastroenterology and Digestive Endoscopy, Sandro Pertini Hospital, Rome, Italy 8 Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Edited by: Rukhsana Ahmed, University at Albany, United States

Reviewed by: Meghan Starolis, Quest Diagnostics, United States; Jing Yuan, Children’s Hospital of Capital Institute of Pediatrics, China

*Correspondence: Wandong Hong, xhnk-hwd@163.com; Jingye Pan, studypanjingye@sina.com

This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology

†These authors have contributed equally to this work

13 07 2021 2021 11 550456 15 04 2020 25 06 2021 Copyright © 2021 Hong, Chen, Qian, Basharat, Zimmer, Wang, Zippi and Pan 2021 Hong, Chen, Qian, Basharat, Zimmer, Wang, Zippi and Pan

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Objectives

The objective of this study was to investigate the clinical features and laboratory findings of patients with and without critical COVID-19 pneumonia and identify predictors for the critical form of the disease.

Methods

Demographic, clinical, and laboratory data of 63 COVID-19 pneumonia patients were retrospectively reviewed. Laboratory parameters were also collected within 3–5 days, 7–9 days, and 11–14 days of hospitalization. Outcomes were followed up until March 12, 2020.

Results

Twenty-two patients developed critically ill pneumonia; one of them died. Upon admission, older patients with critical illness were more likely to report cough and dyspnoea with higher respiration rates and had a greater possibility of abnormal laboratory parameters than patients without critical illness. When compared with the non-critically ill patients, patients with serious illness had a lower discharge rate and longer hospital stays, with a trend towards higher mortality. The interleukin-6 level in patients upon hospital admission was important in predicting disease severity and was associated with the length of hospitalization.

Conclusions

Many differences in clinical features and laboratory findings were observed between patients exhibiting non-critically ill and critically ill COVID-19 pneumonia. Non-critically ill COVID-19 pneumonia also needs aggressive treatments. Interleukin-6 was a superior predictor of disease severity.

COVID-19 infection pneumonia severity critically ill predictor

香京julia种子在线播放

    1. <form id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></form>
      <address id=HxFbUHhlv><nobr id=HxFbUHhlv><nobr id=HxFbUHhlv></nobr></nobr></address>

      Highlights

      The mortality rate in critically ill patients is low.

      Different severity of diseases has different clinical and laboratory results.

      Non-critically ill COVID-19 pneumonia also needs aggressive treatments.

      Interleukin-6 is a good predictor of critically ill COVID-19 pneumonia.

      Interleukin-6 is associated with length of hospitalization

      Introduction

      Novel coronavirus (COVID-19) pneumonia is a newly recognized disease that has spread rapidly throughout China, originating from Wuhan (Hubei province) and expanding to other provinces within the country and around the world (Yang et al., 2020). The current novel coronavirus has surpassed Severe Acute Respiratory Syndrome (SARS) in terms of the number of recorded cases and deaths from the disease (Peeri et al., 2020). The clinical spectrum of COVID-19 pneumonia ranges from mild to critically ill (Yang et al., 2020). Yang et al. have reported on clinical courses and outcomes of critically ill patients with COVID-19 pneumonia in Wuhan, China (Yang et al., 2020). There has been no comparison of data between patients with and without severe COVID-19 pneumonia. In addition, critically ill patients had a high mortality rate of 61·5% and often had to be transferred to an intensive care unit (ICU). Therefore, it is important to recognize predictors of disease severity in the early phase of COVID-19 infection. This could help select patients who could benefit from close surveillance or aggressive interventions. Early case recognition and classification of disease severity improves clinical outcomes (Liao et al., 2020).

      Therefore, our study aimed to investigate the clinical features of COVID-19 pneumonia in patients who were critically ill vs. those who were non-critically ill and identify possible predictors of disease severity.

      Materials and Methods Study Design, Subject Selection

      We conducted a retrospective cohort study in the First Affiliated Hospital of Wenzhou Medical University in mainland China. All patients with confirmed COVID-19 pneumonia between January 29, 2020 and March 12, 2020 were eligible for inclusion in this study. A confirmed case of COVID-19 was defined as exhibiting a positive result on high-throughput sequencing or real-time reverse-transcriptase–polymerase chain reaction (RT-PCR) assay of nasal and pharyngeal swab specimens (Guan et al., 2020). Exclusion criteria were the unavailability of chest computed tomography (CT) scans.

      Definition of Severity

      According to the China Guidelines for the Diagnosis and Treatment Plan of COVID-19 Infection (2020; Xu Y. H. et al., 2020), COVID-19 infections are classified into four types on admission: critically severe type with any of the following: respiratory failure needing mechanical ventilation, shock, or combination with different organ failure requiring admission into an intensive care unit (ICU); severe type with any of the following: respiratory distress with respiratory rate>30 times/minutes, oxygen saturation at rest <93%, or PaO2/FiO2 <300 mmHg; common with fever, respiratory symptoms, and imaging presentations of pneumonia; and, mild with slight clinical symptoms but no imaging presentations of pneumonia (2020).

      For comparative analysis, we also defined the degree of severity of critically ill vs. non critically ill cases of COVID-19 according to a previous study (Kumar et al., 2009). Critically ill patients were defined as those admitted to the ICU and either required mechanical ventilation or had a fraction of inspired oxygen (FiO2) value of at least 60% or more during hospitalization (Kumar et al., 2009; Yang et al., 2020). The date of disease onset was defined as the day when the symptoms were first noticed (Wang et al., 2020).

      Data Collection, Follow up and Ethics

      The epidemiological, clinical, laboratory, radiologic, and treatment and outcomes data during the course of hospitalization were obtained with data collection forms from electronic medical records. The date of disease onset was defined as the day when the symptoms were noticed (Wang et al., 2020). Fever was defined as any value over normal body temperature (>37.0°C) during the time from symptoms to admission. Also, body temperature was measured at admission as a sign of the disease. Chronic concomitant diseases, alcohol consumption and smoking were also recorded at the time of admission (Hong et al., 2017; Hong et al., 2020). Longitudinal data of laboratory parameters at different time points, i.e. within 24 h, 3–5 days, 7–9 days, and 11–14 days after admission, were collected and analyzed. Outcomes were followed up until March 12, 2020.

      This study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University. It was performed according to the principles expressed in the Declaration of Helsinki, and informed consent was obtained from all the subjects.

      Statistical Analysis

      The Shapiro-Wilk test was used to determine if the continuous data follow a normal distribution (Hong et al., 2020). Continuous values were expressed by mean ± SD or median and Inter Quartile Range (IQR) and compared using one-way analysis of variance (ANOVA) or the Kruskal-Wallis non-parametric test. Categorical values were described by count and proportions and compared by the χ2 test or Fisher’s exact test.

      The area under the receiver operating characteristic (ROC) curve (AUC) was used to evaluate the performance of the predictors. A larger AUC value is indicative of greater diagnostic accuracy of a variable (Hong et al., 2011). An AUC above 0·8 indicates good diagnostic accuracy for a variable (Hong et al., 2017). The best cut-off point was set as the point where the number of false positives is as low as possible (specificity>95%) and is determined by selecting a threshold value at the point where the longest increase in the sensitivity of the slope declines (Hong et al., 2017). The sensitivity, specificity, negative predictive value, positive predictive value, positive likelihood ratio, negative likelihood ratio, and diagnostic accuracy were all calculated for the various corresponding cut-off values.

      Pearson correlation and linear regression analysis were used to investigate the relationship between predictor and length of hospitalization. The variables with skewed distribution were log-transformed for correlation analysis when necessary. Differences were considered to be statistically significant if the two-tailed P value was less than 0.05.

      Results Clinical Characteristics

      A total of 63 hospitalized patients confirmed to have COVID-19 pneumonia were enrolled in our study. Twenty-eight patients were imported cases who had traveled from Wuhan City ( Supplementary Figure 1 ). None of the medical staff were infected. As shown in Table 1 , the mean age of the pneumonia patients was 55·9 ± 15·3 (range: 17-92) years. Forty-one (65·1%) patients were men. The mean time from onset of symptoms to admission into our hospital was 6·9 ± 3·7 days. A few of the patients had a history of smoking (17·5%) and alcohol intake (16·0%). Twenty-seven (42·9%) patients had chronic concomitant diseases. The most common symptoms at the onset of the illness were fever (98·4%), cough (61·94%) and sputum (34·9%). However, 16 (25·4%) patients had normal body temperatures at admission. This means that the fever maybe not persist from onset to admission. Sixty-one (96·8%) of the patients had bilateral involvement of pneumonia in chest CT images ( Table 1 ). The typical findings from chest CT images upon admission were local high-density patches, masses ( Supplementary Figure 2A ), and ground-glass opacity ( Supplementary Figure 2B ).

      Baseline characteristics of 63 patients infected with COVID-19 pneumonia on admission.

      Characteristic Total number (N=63) Non- Critically ill (N=41) Critically ill (N=22) P-value
      Median age, years (IQR) 56 ± 15 52·9 ± 14·9 61·5 ± 14·7 0·034
      Male sex, N (%) 41 (65·1) 26 (63·4) 15 (68·2) 0·705
      Time from symptoms to admission, days 6·9 ± 3·7 6·9 ± 4·0 6·8 ± 2·8 0·939
      Epidemic data 0.847
       Travelled from Wuhan, N (%) 25 (38·1) 16 (39·0) 9 (40·9)
       Contacted to case, N (%) 14 (22·2) 10 (24·4) 4 (18·2)
       Occult history, N (%) 24 (39·7) 15 (36·6) 9 (40·9)
      Median BMI 25·2 (22·3–26·9) (N=40) 24·5 (22.1–26.4) (N=28) 25·9 (24·5–29·0) (N=12) 0·165
      Smoking, N (%) 11 (17·5) 6 (14·6) 5 (22·7) 0·420
      Alcohol, N (%) 10 (16·0) 6 (14·6) 4 (18·2) 0·713
      Chronic concomitant diseases, N (%) 27 (42·9) 15 (36·6) 12 (54·6) 0·170
       Hypertension, N (%) 21 (33·3) 12 (29·3) 9 (40·9) 0·407
       Diabetes mellitus, N (%) 9 (14·3) 4 (9·8) 5 (22·7) 0·256
       Malignancy, N (%) 2 (3·2) 0 (0) 2 (9·1) 0·118
       Cardiovascular, N (%) 2 (3·2) 2 (4·9) 0 (0) 0·538
       Neurologic, N (%) 1 (1·6) 1 (2·4) 0 (0) 1·000
       Pulmonary, N (%) 1 (1·6) 0 (0) 1 (4·5) 0·349
       Hepatitis virus carrier, N (%) 1 (1·6) 1 (2·4) 0 (0) 1·000
      Symptoms
       Fever, N (%) 62 (98·4) 40 (97·6) 22 (100) 1·000
       Cough, N (%) 39 (61·9) 21 (51·2) 18 (81·8) 0·028
       Sputum, N (%) 22 (34·9) 12 (29·3) 10 (45·5) 0·269
       Dyspnoea, N (%) 17 (27·0) 4 (9·8) 13 (59·1) <0·001
       Chills, N (%) 15 (23·8) 12 (29·3) 3 (13·6) 0·222
       Fatigue, N (%) 8 (12·7) 4 (9·8) 4 (18·2) 0·434
       Sore throat, N (%) 7 (11·1) 6 (14·6) 1 (4·6) 0·405
       Headache, N (%) 3 (4·8) 3 (7·3) 0 (0) 0·546
       Myalgia, N (%) 4 (6·4) 2 (4·9) 2 (9·1) 0·606
       Diarrhea, N (%) 3 (4·8) 2 (4·9) 1 (4·6) 1·000
      Signs
       Distribution of temperature 0.128
        <37·0, N (%) 16 (25·4) 14 (34·1) 2 (9·1)
        37·0-37·4, N (%) 17 (27·0) 9 (22·0) 8 (36·4)
       37·5-38·0, N (%) 15 (23·8) 10 (24·4) 5 (22·7)
       38·1-39, N (%) 14 (22·2) 7 (17·1) 7 (31·8)
       >39, N (%) 1 (1·6) 1 (2·4) 0 (0)
       Mean arterial pressure (IQR), mmHg 99·0 ± 11·5 98·6 ± 11·4 99·6 ± 11·9 0·741
       Heart rate, bpm 87·1 ± 16·0 88·2 ± 16·7 84·9 ± 14·7 0·438
       Respiratory rate 20 (20–23) 20 (20–20) 23·5 (20–28) 0·004
      Location of CT findings 0·538
       Unilateral pneumonia 2 (3·2) 2 (4·9) 0 (0)
       Bilateral pneumonia 61 (96·8) 39 (95·1) 22 (100)

      Data are shown either as the number of observations, percentage, or median and interquartile range.

      As shown in Figure 1 , upon admission, there were 13, 42, and 8 patients with common type, severe type, and critically severe type pneumonia, respectively, in our study. One COVID-19 pneumonia patient from the common type group and 13 COVID-19 pneumonia patients from the severe type group progressed to the critically ill type during hospitalization. Therefore, of the 63 patients, 22 (34·9%) required high-flow nasal cannula at a later stage or higher-level oxygen support measures to correct hypoxemia during hospitalization and were classified as critically ill patients, while the remainder (41 patients) were recorded as non-critically ill patients.

      Classifications of the severity of COVID-19-related pneumonia on admission, types of oxygen inhalation, and clinical outcomes. Light yellow indicates COVID-19 pneumonia patients with non-critical illness; light red indicated patients with critical illness.

      As shown in Table 1 , in comparison with the non-critically ill patients, patients with critical illness were generally older and were more likely to report cough and dyspnoea with higher respiratory rate frequency.

      Laboratory Findings

      Upon admission, data regarding levels of D-dimer (full data available for 58 patients), B-type natriuretic peptide (full data available for 62 patients), and interleukin-6 (IL-6) (full data available for 46 patients) were obtained. As shown in Table 2 , in comparison to the non-critically ill patients, patients with critical illness had higher white blood cell and neutrophil counts, as well as higher levels of aspartate transaminase, blood urea nitrogen, creatine, D-dimer, creatine kinase, B-type natriuretic peptide, C-reactive protein, procalcitonin, and interleukin-6. Besides, patients with severe pneumonia had more severe hypoalbuminemia than patients exhibiting less critical forms of the disease.

      Comparison of laboratory findings, treatment measures and clinical outcomes between critically and non-critically ill COVID-19 pneumonia patient groups.

      Characteristic Normal range Non-Critically ill (N=41) Critically ill(N=22) P-value
      Laboratory findings
       Leukocyte (109/L) 3.5–9.5 5·1 (4·3–7.2) 9·5 (7·8–12·4) 0·001
       Lymphocyte (109/L) 1.1–3.2 0·9 (0·72–1·17) 0·67 (0·44–1·07) 0·059
       Neutrophil (109/L) 1.80–6.3 3·69 (2·81–5·45) 8·06 (5·13–9·84) 0·002
       Platelet (109/L) 125–350 219 (168–296) 196 (155–231) 0·056
       Total bilirubin, mmol/L 0–20 11 (8–15) 12·5 (8–17) 0·406
       Alanine aminotransferase, U/L 9–50 24 (20–42) 38·5 (21–69) 0·217
       Aspartate transaminase, U/L 15–40 28 (23–38) 50 (35–83) 0·001
       Albumin, (mg/dL) 40.0–55.0 34·4 ± 4·6 30·8 ± 3·7 0·002
       Blood urea nitrogen, mmol/L 2.8–7.2 4·7 (3·4–5·9 5·5 (4·9–6·9) 0·014
       Creatinine, μmol/L 44–97 60 (55–67) 68·5 (58–83) 0·030
       Glucose, mmol/L 3.9–6.1 7·4 (5·7–10·7) 9·3 (8–9·6) 0·121
       Prothrombin time 11.5–14.6 15·9 (15·3–16·8) 16·2 (15·7–16·8) 0·829
       Fibrinogen (N=57), g/L 2.00–4.00 5·35 (4·65–6·35) (N=38) 6·05 (5·16–6·84) (N=19) 0·101
       D-dimer (N=58), mg/L 0.00–0.50 0·68 (0·48–0·98) (N=36) 1·14 (0·68–1·47) (N=22) 0·009
       Creatine kinase, U/L 0.00–4.87 69 (52–90) 147·5 (64–283) 0·014
       B-type natriuretic peptide (N=62), pg/ml 0.00–125.0 18·5 (10–53·5) (N=40) 64·5 (19–152) (N=22) 0·002
       C-reactive protein, mg/L 0.0–6.0 20·4 (14·9–47·6) 54 (24·1–90) 0·021
       Procalcitonin, ng/mL 0-0.5 0·06 (0·04–0·08) 0·12 (0·06–0·20) 0·001
       Interleukin-6 (N=46), pg/ml <3 8·4 (4·0–32·2) (N=30) 76·1 (32·2–103·1) (N=16) <0·001
      Treatment*
       High flow nasal cannula, N (%) 0 18 (81·8) <0·001
       Mechanical ventilation, N (%) 0 16 (72·7) <0·001
       Non-invasive, N (%) 0 14 (63·6) <0·001
       invasive, N (%) 0 10 (45·5) <0·001
       Extracorporeal membrane oxygenation, N (%) 0 6 (27·3) <0·001
       Antibiotics, N (%) 31 (75·6) 21 (95·5) 0·079
       Antiviral, N (%)
        Kaletra, N (%) 33 (80·5) 19 (86·4) 0·733
         Arbidol, N (%) 39 (95·1) 21 (95·5) 1·000
       methylprednisolone, N (%) 8 (19·5) 19 (86·4) 0·001
       thymosin alpha 1, N (%) 10 (24·4) 16 (72·7) <0·001
       Intravenous immunoglobulin, N (%) 8 (19·5) 13 (59·1) <0·001
       blood plasma transfusion, N (%) 1 (2·4) 11 (50·0) <0·001
       Intravenous albumin, N (%) 22 (53·7) 21 (95·5) 0·001
      Outcomes
       Hospitalization, N (%) 0 (0) 5 (22·7) 0·004
       Discharge, N (%) 41 (100) 15 (68·2) <0·001
       Hospital days, N (%) 17·2 ± 6·7 24·1 ± 5·5 <0·001
       Death, N (%) 0 (0) 1 (4.5) 0·118

      *Patients may receive more than one treatment item.

      As shown in Figure 2 , longitudinal data revealed that statistical difference was still significant between COVID-19 pneumonia patient groups (critically ill vs non-critically ill) in terms of counts or levels of white blood cells, neutrophils, aspartate transaminase, blood urea nitrogen, and D-dimer within 3–5 days, 7–9 days, and 11–14 days of hospitalization. There was a significant statistical difference recorded for albumin and B-type natriuretic peptide levels between both groups within 3–5 or 7–9 days of hospitalization, but not within 11–14 days of hospitalization. A significant statistical difference was also observed for the interleukin-6 levels between the two groups within 7–9 days and 11–14 days of hospitalization. Compared to patients not critically ill with pneumonia, critically ill patients had lower lymphocyte counts within 3–5 days, 7–9 days, and 11–14 days of hospitalization. And the lymphocyte numbers gradually increased with the duration of hospitalization in pneumonia patients irrespective of disease severity.

      Longitudinal analysis of twelve laboratory parameters altered during the hospitalization in critically and non-critically ill patients.

      Treatment and Outcomes

      A high flow nasal cannula was initially used in the treatment of 18 patients, of which 6 belonged to the critically ill group and strictly required a high flow nasal cannula, while the rest (12 patients) were switched to mechanical ventilation or extracorporeal membrane oxygenation (ECMO) ( Table 2 and Figure 1 ). Ultimately, mechanical ventilation was performed in 16 patients, 6 of whom received ECMO as rescue therapy ( Figure 1 ).

      A total of 52 (82·5%) patients received empirical antibiotic therapy (moxifloxacin, 33 [52·4%]; tazocin, 18 [18·6%]; ceftazidime, 6 [9·5%]; and Piperacillin, 6 [9·5%]) and antiviral therapy (Kaletra, 52 [82·5%] and Arbidol, 60 [95·2%]). Twenty-seven (42·9%) patients were given systematic methylprednisolone, while 26 (41·3%) patients received thymosin alpha 1. Additionally, intravenous immunoglobulin, blood plasma transfusion, and intravenous albumin were administered in 21 (33·3%), 12 (19·1%), and 43 (68·3%) patients, respectively. When compared to the non-critically ill group of patients, critically ill patients were given a higher dose of methylprednisolone, thymosin alpha 1, intravenous immunoglobulin, blood plasma transfusion, and intravenous albumin therapy ( Table 2 ).

      As of March 12, 2020, six critically ill patients were still hospitalized. Among these, four had been transferred to the general wards because of improved condition, while the remaining two patients, who are 79 and 92 years old, respectively, and are both supported by ECMO, are still in the ICU. A total of 56 patients (88.9%) have been discharged, and one patient (1·6%) died. The patient who died was 79 years old and underwent ECMO therapy before death. When compared with the non-critically ill patient group, critically ill patients had a lower discharge rate (68·2% vs. 100%, p<0·001), longer hospital stays (24·1 vs. 17·2 days, p<0·001), and a trend towards higher mortality (4·5% vs. 0, p=0·349) ( Table 2 ).

      Interleukin-6 in Predicting the Severity of COVID-19 Pneumonia

      Upon admission, the parameters that reached a statistically significant difference between patients with and without critical illness include age, presence of cough and dyspnoea, respiratory rate, white blood cell counts, neutrophil counts, and levels of aspartate transaminase, albumin, blood urea nitrogen, creatine, D-dimer, creatine kinase, B-type natriuretic peptide, C-reactive protein, procalcitonin, and interleukin-6. These were evaluated as potential predictors of severe COVID-19 pneumonia. Based on the ROC curve analysis, among single predictors, interleukin-6 has the highest AUC (0·85), indicative of excellent diagnostic accuracy ( Figure 3 ). Further analysis revealed that there was a positive correlation between IL-6 levels and duration of hospital stay (R=0·58, p=0·0001) ( Figure 4 ).

      Forest plot for accuracy of various markers in predicting critical COVID-19-related pneumonia. Each marker is plotted as an area under the curve of the receiver operating characteristic curve (AUC) with a 95% confidence interval.

      Relationship between IL-6 levels and length of hospitalization of COVID-19-related pneumonia patients (data were available for 46 patients).

      It was also inferred from the ROC curve analysis that the optimum cut-off value for interleukin-6 was 77·5 pg/mol. The sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, positive predictive value, negative predictive value, and diagnostic accuracy were 50, 96·7, 15, 0·52, 88·9, 78·4, and 80·4%, respectively.

      Using a cut-off value of 77·5 and the incidence of severe pneumonia (34·8% in this study) as the pre-test probability, the resulting Fagan plot ( Figure 5 ) shows that interleukin-6 levels can be clinically informative, as it increases the probability of the patient being classified into the hypoxemia group by up to 89% when positive, and lowers the probability by up to 22% when negative.

      Fagan plot of IL-6 for the hospital stay prediction of critically ill COVID-19 patients (data were available for 46 patients).

      Discussion

      The earliest patient was an imported case who had a history of travel from Wuhan City, and the latest patient had an occult epidemic history ( Supplementary Figure 1 ). A total of 28 (38·1%) patients were imported cases that had immediate travel history from Wuhan city. Fourteen (22·2%) patients had a history of direct exposure to confirmed patients. The rapid human-to-human transmission among close contacts is an important feature of COVID-19 infection (Wang et al., 2020). Early restriction of patient contact may reduce transmission of the disease. If individuals come into contact with confirmed patients with a history of travel to epidemic areas, such as Wuhan, they would be quarantined at designated hospitals for at least two weeks. Twenty-four (39·7%) patients had an occult epidemic history. This highlights the importance of not neglecting the possibility of transmission from asymptomatic patients, since most (80%) patients with COVID-19 infection would be mild and asymptomatic (Tian et al., 2020).

      On average, critically ill patients were shown to be older than non-critically ill patients (61·5 vs. 52·9 years old, p<0·034) ( Table 1 ). As of March 12, 2020, one patient died, while two were still alive but critically ill ( Figure 1 ). The patient who died was 79 years old and underwent ECMO therapy before death. Zhou et al. (2020) showed that older age is one of the risk factors for mortality in adult inpatients with COVID-19 in Wuhan. In our cohort, fever was the most common symptom at the onset of the illness in patients with COVID-19 pneumonia ( Table 1 ) occurring in 62 patients (98·4%), followed by cough (61·94%) and sputum (34·9%), which is in accordance with previous studies (Guan et al., 2020; Wang et al., 2020). The remaining patient was asymptomatic and had no fever from the moment of admission until the time he was discharged. He was hospitalized because he had a history of direct exposure to confirmed patients and evidence of pneumonia based on chest CT images. In addition, 16 (25·4%) patients had normal body temperatures at admission. These findings suggest that a normal fever scan cannot accurately diagnose COVID-19 pneumonia. An RT-PCR test and chest CT images may be useful in identifying COVID-19 pneumonia early and accurately in individuals that have an exposure history, although it is not known whether these measures are cost-effective or not. It also implies that measuring only the body temperature may not successfully identify all patients among individuals in public places such as airports, hospitals, and schools; 52·4% of patients had a temperature of <37·5°C, and only 1·6% of patients had a high temperature, i.e. >39·0°C ( Table 2 ). These findings are consistent with a previous report by Guan et al. (2020). When compared with the non-critically ill patients, the patient group exhibiting critical illness had a higher incidence of cough and dyspnoea and a higher respiratory rate. These symptoms could be partly explained by histological findings from COVID-2019 pneumonia patients, in which lung tissue displayed pulmonary edema with hyaline membrane formation and desquamation of pneumocytes, indicating acute respiratory distress syndrome (Xu Z. et al., 2020).

      Patients belonging to the critically ill group had higher white blood cell counts, neutrophil counts, and D-dimer levels than patients in the non-critically ill group. This indicated that severely ill patients get a stronger inflammatory response, as well as activation of coagulation induced by viral infection. Lymphocytopenia may be associated with cellular immune deficiency. Yang et al. suggested that the severity of lymphocytopenia may reflect the severity of COVID-2019 infection (Yang et al., 2020). Our study found that there was a trend for lower total lymphocytes in patients belonging to the critically ill group than those in the non-critically ill group, although it did not reach statistical significance upon admission (p=0·059). Longitudinal data indicated that when compared to non-critically ill COVID-19 pneumonia patients, critically ill patients had lower lymphocyte counts within 3–5 days, 7–9 days, and 11–14 days of hospitalization ( Figure 2 ). Critically ill patients also had hypoalbuminemia and increased levels of aspartate transaminase, blood urea nitrogen, creatine, creatine kinase, B-type natriuretic peptide, which are more indicative of severe hepatic, kidney and myocardial injury (Wang et al., 2020). It has been shown that, similar to SARS-CoV, the COVID-19 virus exploits the angiotensin converting enzyme 2 (ACE2) receptor to gain entry into the cells (Baig et al., 2020). The most remarkable finding was the surface expression of ACE2 protein on lung alveolar epithelial cells and enterocytes of the small intestine (Hamming et al., 2004). Furthermore, ACE2 was present in arterial and venous endothelial cells and arterial smooth muscle cells in all tissues studied, including liver, kidney, cardiovascular, and brain tissues (Hamming et al., 2004).

      Rapid production of IL-6 contributes to host defense during infection and tissue injury, but excessive IL-6 production causes severe inflammatory diseases (Kang et al., 2019). Our study showed that patients who were in critical condition had higher IL-6 levels than patients who were not (76·1 vs. 8·4 pg/mL, p<0·001) ( Table 2 ). This means that severe COVID-19 infection could result in a cytokine storm. Our study showed that there was a good positive correlation between IL-6 levels and the length of hospitalization. Higher IL-6 levels were associated with longer hospital stays (R=0·58, p=0·0001) ( Figure 4 ). Based on the ROC curve analysis, the AUC and the optimum cut-off value of interleukin-6 as a predictor of critical COVID-19 pneumonia cases were 0·85 and 77·5 pg/mol, respectively. The sensitivity, specificity, and diagnostic accuracy were 50, 96·7, and 80·4%, respectively. Using the incidence of critically ill COVID-19 pneumonia as the pre-test probability, the resulting Fagan plot shows that interleukin-6 can be clinically informative, as it increases the probability of a patient being classified into the hypoxemia group by up to 89% when positive and lowers the probability to 22% when negative ( Figure 5 ). Longitudinal data also indicated a significant IL-6 decrease after hospitalization in both patients with and without critical stage COVID-19 pneumonia ( Figure 2 ). There is evidence that IL-6 blockade strategy is beneficial for several inflammatory diseases, such as rheumatoid arthritis, juvenile idiopathic arthritis (Kang et al., 2019). It would be interesting to conduct a randomized clinical trial to test whether interfering with the IL-6 signalling axis in COVID-19 pneumonia patients is effective in treating the disease.

      Yang et al. suggested that for non-critically ill patients, close follow-up is likely to be sufficient to manage the disease (Yang et al., 2020). Our study showed that patients with non-critical illness upon admission may advance to a critical stage later on. As shown in Figure 1 , one COVID-19 pneumonia patient in the common type group and 13 patients in the severe type group advanced to the critically ill stage during hospitalization. This means that both critically ill and non-critically ill COVID-19 pneumonia patients need close monitoring and aggressive treatments.

      Until now, no specific treatment has been recommended for coronavirus infections, except for meticulous supportive care (Wang et al., 2020). Mechanical ventilation is the main supportive treatment for critically ill patients (Yang et al., 2020). Three (50%) of the six patients who used ECMO recovered and got discharged. ECMO is an excellent candidate for refractory hypoxemia caused by severe acute respiratory distress syndrome, if it can be delivered in a medical center that has experience of using this form of therapy (Mi et al., 2018). Even without solid evidence for the effectiveness of antibacterial or antiviral therapies in the treatment of COVID-19 infections, 82·5% (52/63) of patients received antibacterial agents and nearly all the patients received antiviral therapy. For this study, we used Kaletra and Arbidol. A study on the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) showed that the timing of the start of treatment with antiviral agents is important in most viral infections, and starting antiviral treatment early might lead to better outcomes (Momattin et al., 2013).

      When compared with the non-critically ill patients in our study, the critically ill ones received higher levels of methylprednisolone (86·4% vs. 19·5%, p=0·001). The dose of methylprednisolone varied depending on disease severity (Wang et al., 2020). Systemic corticosteroids were shown to delay viral clearance in critically ill patients with MERS-CoV (Memish et al., 2020). However, a study on severe acute respiratory syndrome (SARS) suggested that the use of interferon alfacon-1 plus corticosteroids was associated with reduced disease-associated impaired oxygen saturation and more rapid resolution of radiographic lung abnormalities (Loutfy et al., 2003). Wu et al. reported that treatment with methylprednisolone may be beneficial for patients with COVID-19 pneumonia who develop acute respiratory distress syndrome (Wu et al., 2020).

      When compared with the non-critically ill patients, critically ill ones had a lower discharge rate (68·2% vs. 100%, p<0·001) and longer hospital days (24·1 vs. 17·2 days, p<0·001), as well as a trend towards higher mortality (4·5% vs. 0, p=0·349). The mortality of critically ill patients in our study was significantly lower than that reported by Yang et al. in Wuhan (4·5% vs. 61·5%) (Yang et al., 2020). Early isolation, early diagnosis, and early management might have collectively contributed to the reduction in mortality (Guan et al., 2020). In addition, thymosin alpha 1, intravenous administration of immunoglobulin, blood plasma transfusion and intravenous albumin therapy may also improve the clinical outcome.

      The limitation of this study is that it is a retrospective study from a single center, and the sample size was small. Patients had a variety of different treatments (for example: antivirals, antibiotics, intravenous immunoglobulin, blood plasma transfusion, and intravenous albumin). This made it very difficult to interpret any other outcome data objectively. Therefore, it would be interesting to conduct a randomized clinical trial to assess the effect of different therapeutic strategies for patients with or without COVID-19 pneumonia in future studies. Additionally, only patients with pneumonia were enrolled, so our results may be not applicable to patients without pneumonia.

      Conclusions

      In conclusion, both critically ill and non-critically ill COVID-19 pneumonia patients need close monitoring and aggressive treatments. There was a statistically significant difference between critically ill and non-critically ill COVID-19 pneumonia patients in terms of age, some symptoms, laboratory findings, treatments, and outcomes. Interleukin-6 levels upon admission is a good predictor of the disease, and it is associated with the length of hospitalization.

      Data Availability Statement

      The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

      Ethics Statement

      This study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Wenzhou Medical University. The committee decided to waive the need for written informed consent from the participants studied in this analysis as the data were analyzed retrospectively and anonymously.

      Author Contributions

      WH conceived the study and carried out the majority of the work. WH, QC, SQ, YW, and JP participated in data collection. WH conducted data analysis and drafted the manuscript. ZB, VZ, MZ, and JP helped to finalize the manuscript. All authors contributed to the article and approved the submitted version.

      Funding

      This work was supported by Wenzhou Science and Technology Bureau (Number: Y2020010) and Wenzhou Key Technology Breakthrough Program on Prevention and Treatment for COVID-19 Epidemic, No. ZG2020012.

      Conflict of Interest

      The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

      Supplementary Material

      The Supplementary Material for this article can be found online at: /articles/10.3389/fcimb.2021.550456/full#supplementary-material

      Bar graph depicting travel history of patients with COVID-19-related pneumonia.

      Representative computed tomography images from a patient with COVID-19-related pneumonia. (A) High-density local patches and masses are seen, and the edges are blurred and thickened in the left lung; (B) Ground glass opacities in two lungs.

      References (2020) Notice on the Novel Coronavirus Infection Diagnosis and Treatment Plan (Trial Version Fifth). Available at: http://www.nhc.gov.cn/yzygj/s7653p/202002/3b09b894ac9b4204a79db5b8912d4440.shtml. Baig A. M. Khaleeq A. Ali U. Syeda H. (2020). Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem. Neurosci. 11 (7), 995998. doi: 10.1021/acschemneuro.0c00122 Guan W. J. Ni Z. Y. Hu Y. Liang W. H. Ou C. Q. He J. X. . (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 382 (18), 17081720. doi: 10.1056/NEJMoa2002032 Hamming I. Timens W. Bulthuis M. L. Lely A. T. Navis G. Van Goor H. (2004). Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis. J. Pathol. 203, 631637. doi: 10.1002/path.1570 Hong W. Dong L. Huang Q. Wu W. Wu J. Wang Y. (2011). Prediction of Severe Acute Pancreatitis Using Classification and Regression Tree Analysis. Dig. Dis. Sci. 56, 36643671. doi: 10.1007/s10620-011-1849-x Hong W. Lin S. Zippi M. Geng W. Stock S. Basharat Z. . (2017). Serum Albumin Is Independently Associated With Persistent Organ Failure in Acute Pancreatitis. Can. J. Gastroenterol. Hepatol. 2017, 5297143. doi: 10.1155/2017/5297143 Hong W. Zimmer V. Basharat Z. Zippi M. Stock S. Geng W. . (2020). Association of Total Cholesterol With Severe Acute Pancreatitis: A U-Shaped Relationship. Clin. Nutr. 39, 250257. doi: 10.1016/j.clnu.2019.01.022 Kang S. Tanaka T. Narazaki M. Kishimoto T. (2019). Targeting Interleukin-6 Signaling in Clinic. Immunity 50, 10071023. doi: 10.1016/j.immuni.2019.03.026 Kumar A. Zarychanski R. Pinto R. Cook D. J. Marshall J. Lacroix J. . (2009). Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada. JAMA 302, 18721879. doi: 10.1001/jama.2009.1496 Liao X. Wang B. Kang Y. (2020). Novel Coronavirus Infection During the 2019-2020 Epidemic: Preparing Intensive Care Units-the Experience in Sichuan Province, China. Intensive Care Med. 46, 357360. doi: 10.1007/s00134-020-05954-2 Loutfy M. R. Blatt L. M. Siminovitch K. A. Ward S. Wolff B. Lho H. . (2003). Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory Syndrome: A Preliminary Study. JAMA 290, 32223228. doi: 10.1001/jama.290.24.3222 Memish Z. A. Perlman S. Van Kerkhove M. D. Zumla A. (2020). Middle East Respiratory Syndrome. Lancet 395 (10229), 10631077. doi: 10.1016/S0140-6736(19)33221-0 Mi M. Y. Matthay M. A. Morris A. H. (2018). Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N. Engl. J. Med. 379, 884887. doi: 10.1056/NEJMclde1804601 Momattin H. Mohammed K. Zumla A. Memish Z. A. Al-Tawfiq J. A. (2013). Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–possible Lessons From a Systematic Review of SARS-CoV Therapy. Int. J. Infect. Dis. 17, e792e798. doi: 10.1016/j.ijid.2013.07.002 Peeri N. C. Shrestha N. Rahman M. S. Zaki R. Tan Z. Bibi S. . (2020). The SARS, MERS and Novel Coronavirus (COVID-19) Epidemics, the Newest and Biggest Global Health Threats: What Lessons Have We Learned? Int. J. Epidemiol. 49 (3), 717726. doi: 10.1093/ije/dyaa033 Tian S. Hu N. Lou J. Chen K. Kang X. Xiang Z. . (2020). Characteristics of COVID-19 Infection in Beijing. J. Infect. 80 (4), 401406. doi: 10.1016/j.jinf.2020.02.018 Wang D. Hu B. Hu C. Zhu F. Liu X. Zhang J. . (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 323 (11), 10611069. doi: 10.1001/jama.2020.1585 Wu C. Chen X. Cai Y. Xia J. Zhou X. Xu S. . (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 180 (7), 934943. doi: 10.1001/jamainternmed.2020.0994 Xu Y. H. Dong J. H. An W. M. Lv X. Y. Yin X. P. Zhang J. Z. . (2020). Clinical and Computed Tomographic Imaging Features of Novel Coronavirus Pneumonia Caused by SARS-Cov-2. J. Infect. 80 (4), 394400. doi: 10.1016/j.jinf.2020.02.017 Xu Z. Shi L. Wang Y. Zhang J. Huang L. Zhang C. . (2020). Pathological Findings of COVID-19 Associated With Acute Respiratory Distress Syndrome. Lancet Respir. Med. 8 (4), 420422. doi: 10.1016/S2213-2600(20)30076-X Yang X. Yu Y. Xu J. Shu H. Xia J. Liu H. . (2020). Clinical Course and Outcomes of Critically Ill Patients With SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. Lancet Respir. Med. 8 (5), 475481. doi: 10.1016/S2213-2600(20)30079-5 Zhou F. Yu T. Du R. Fan G. Liu Y. Liu Z. . (2020). Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet 395 (10229), 10541062. doi: 10.1016/S0140-6736(20)30566-3
      ‘Oh, my dear Thomas, you haven’t heard the terrible news then?’ she said. ‘I thought you would be sure to have seen it placarded somewhere. Alice went straight to her room, and I haven’t seen her since, though I repeatedly knocked at the door, which she has locked on the inside, and I’m sure it’s most unnatural of her not to let her own mother comfort her. It all happened in a moment: I have always said those great motor-cars shouldn’t be allowed to career about the streets, especially when they are all paved with cobbles as they are at Easton Haven, which are{331} so slippery when it’s wet. He slipped, and it went over him in a moment.’ My thanks were few and awkward, for there still hung to the missive a basting thread, and it was as warm as a nestling bird. I bent low--everybody was emotional in those days--kissed the fragrant thing, thrust it into my bosom, and blushed worse than Camille. "What, the Corner House victim? Is that really a fact?" "My dear child, I don't look upon it in that light at all. The child gave our picturesque friend a certain distinction--'My husband is dead, and this is my only child,' and all that sort of thing. It pays in society." leave them on the steps of a foundling asylum in order to insure [See larger version] Interoffice guff says you're planning definite moves on your own, J. O., and against some opposition. Is the Colonel so poor or so grasping—or what? Albert could not speak, for he felt as if his brains and teeth were rattling about inside his head. The rest of[Pg 188] the family hunched together by the door, the boys gaping idiotically, the girls in tears. "Now you're married." The host was called in, and unlocked a drawer in which they were deposited. The galleyman, with visible reluctance, arrayed himself in the garments, and he was observed to shudder more than once during the investiture of the dead man's apparel. HoME香京julia种子在线播放 ENTER NUMBET 0016jouetie.net.cn
      eeniu.com.cn
      ktchain.com.cn
      www.haodin.com.cn
      jscmid.com.cn
      ntlkmzp.net.cn
      www.seqqjo.com.cn
      ryupqm.com.cn
      wbldqh.com.cn
      trade360.net.cn
      处女被大鸡巴操 强奸乱伦小说图片 俄罗斯美女爱爱图 调教强奸学生 亚洲女的穴 夜来香图片大全 美女性强奸电影 手机版色中阁 男性人体艺术素描图 16p成人 欧美性爱360 电影区 亚洲电影 欧美电影 经典三级 偷拍自拍 动漫电影 乱伦电影 变态另类 全部电 类似狠狠鲁的网站 黑吊操白逼图片 韩国黄片种子下载 操逼逼逼逼逼 人妻 小说 p 偷拍10幼女自慰 极品淫水很多 黄色做i爱 日本女人人体电影快播看 大福国小 我爱肏屄美女 mmcrwcom 欧美多人性交图片 肥臀乱伦老头舔阴帝 d09a4343000019c5 西欧人体艺术b xxoo激情短片 未成年人的 插泰国人夭图片 第770弾み1 24p 日本美女性 交动态 eee色播 yantasythunder 操无毛少女屄 亚洲图片你懂的女人 鸡巴插姨娘 特级黄 色大片播 左耳影音先锋 冢本友希全集 日本人体艺术绿色 我爱被舔逼 内射 幼 美阴图 喷水妹子高潮迭起 和后妈 操逼 美女吞鸡巴 鸭个自慰 中国女裸名单 操逼肥臀出水换妻 色站裸体义术 中国行上的漏毛美女叫什么 亚洲妹性交图 欧美美女人裸体人艺照 成人色妹妹直播 WWW_JXCT_COM r日本女人性淫乱 大胆人艺体艺图片 女同接吻av 碰碰哥免费自拍打炮 艳舞写真duppid1 88电影街拍视频 日本自拍做爱qvod 实拍美女性爱组图 少女高清av 浙江真实乱伦迅雷 台湾luanlunxiaoshuo 洛克王国宠物排行榜 皇瑟电影yy频道大全 红孩儿连连看 阴毛摄影 大胆美女写真人体艺术摄影 和风骚三个媳妇在家做爱 性爱办公室高清 18p2p木耳 大波撸影音 大鸡巴插嫩穴小说 一剧不超两个黑人 阿姨诱惑我快播 幼香阁千叶县小学生 少女妇女被狗强奸 曰人体妹妹 十二岁性感幼女 超级乱伦qvod 97爱蜜桃ccc336 日本淫妇阴液 av海量资源999 凤凰影视成仁 辰溪四中艳照门照片 先锋模特裸体展示影片 成人片免费看 自拍百度云 肥白老妇女 女爱人体图片 妈妈一女穴 星野美夏 日本少女dachidu 妹子私处人体图片 yinmindahuitang 舔无毛逼影片快播 田莹疑的裸体照片 三级电影影音先锋02222 妻子被外国老头操 观月雏乃泥鳅 韩国成人偷拍自拍图片 强奸5一9岁幼女小说 汤姆影院av图片 妹妹人艺体图 美女大驱 和女友做爱图片自拍p 绫川まどか在线先锋 那么嫩的逼很少见了 小女孩做爱 处女好逼连连看图图 性感美女在家做爱 近距离抽插骚逼逼 黑屌肏金毛屄 日韩av美少女 看喝尿尿小姐日逼色色色网图片 欧美肛交新视频 美女吃逼逼 av30线上免费 伊人在线三级经典 新视觉影院t6090影院 最新淫色电影网址 天龙影院远古手机版 搞老太影院 插进美女的大屁股里 私人影院加盟费用 www258dd 求一部电影里面有一个二猛哥 深肛交 日本萌妹子人体艺术写真图片 插入屄眼 美女的木奶 中文字幕黄色网址影视先锋 九号女神裸 和骚人妻偷情 和潘晓婷做爱 国模大尺度蜜桃 欧美大逼50p 西西人体成人 李宗瑞继母做爱原图物处理 nianhuawang 男鸡巴的视屏 � 97免费色伦电影 好色网成人 大姨子先锋 淫荡巨乳美女教师妈妈 性nuexiaoshuo WWW36YYYCOM 长春继续给力进屋就操小女儿套干破内射对白淫荡 农夫激情社区 日韩无码bt 欧美美女手掰嫩穴图片 日本援交偷拍自拍 入侵者日本在线播放 亚洲白虎偷拍自拍 常州高见泽日屄 寂寞少妇自卫视频 人体露逼图片 多毛外国老太 变态乱轮手机在线 淫荡妈妈和儿子操逼 伦理片大奶少女 看片神器最新登入地址sqvheqi345com账号群 麻美学姐无头 圣诞老人射小妞和强奸小妞动话片 亚洲AV女老师 先锋影音欧美成人资源 33344iucoom zV天堂电影网 宾馆美女打炮视频 色五月丁香五月magnet 嫂子淫乱小说 张歆艺的老公 吃奶男人视频在线播放 欧美色图男女乱伦 avtt2014ccvom 性插色欲香影院 青青草撸死你青青草 99热久久第一时间 激情套图卡通动漫 幼女裸聊做爱口交 日本女人被强奸乱伦 草榴社区快播 2kkk正在播放兽骑 啊不要人家小穴都湿了 www猎奇影视 A片www245vvcomwwwchnrwhmhzcn 搜索宜春院av wwwsee78co 逼奶鸡巴插 好吊日AV在线视频19gancom 熟女伦乱图片小说 日本免费av无码片在线开苞 鲁大妈撸到爆 裸聊官网 德国熟女xxx 新不夜城论坛首页手机 女虐男网址 男女做爱视频华为网盘 激情午夜天亚洲色图 内裤哥mangent 吉沢明歩制服丝袜WWWHHH710COM 屌逼在线试看 人体艺体阿娇艳照 推荐一个可以免费看片的网站如果被QQ拦截请复制链接在其它浏览器打开xxxyyy5comintr2a2cb551573a2b2e 欧美360精品粉红鲍鱼 教师调教第一页 聚美屋精品图 中韩淫乱群交 俄罗斯撸撸片 把鸡巴插进小姨子的阴道 干干AV成人网 aolasoohpnbcn www84ytom 高清大量潮喷www27dyycom 宝贝开心成人 freefronvideos人母 嫩穴成人网gggg29com 逼着舅妈给我口交肛交彩漫画 欧美色色aV88wwwgangguanscom 老太太操逼自拍视频 777亚洲手机在线播放 有没有夫妻3p小说 色列漫画淫女 午间色站导航 欧美成人处女色大图 童颜巨乳亚洲综合 桃色性欲草 色眯眯射逼 无码中文字幕塞外青楼这是一个 狂日美女老师人妻 爱碰网官网 亚洲图片雅蠛蝶 快播35怎么搜片 2000XXXX电影 新谷露性家庭影院 深深候dvd播放 幼齿用英语怎么说 不雅伦理无需播放器 国外淫荡图片 国外网站幼幼嫩网址 成年人就去色色视频快播 我鲁日日鲁老老老我爱 caoshaonvbi 人体艺术avav 性感性色导航 韩国黄色哥来嫖网站 成人网站美逼 淫荡熟妇自拍 欧美色惰图片 北京空姐透明照 狼堡免费av视频 www776eom 亚洲无码av欧美天堂网男人天堂 欧美激情爆操 a片kk266co 色尼姑成人极速在线视频 国语家庭系列 蒋雯雯 越南伦理 色CC伦理影院手机版 99jbbcom 大鸡巴舅妈 国产偷拍自拍淫荡对话视频 少妇春梦射精 开心激动网 自拍偷牌成人 色桃隐 撸狗网性交视频 淫荡的三位老师 伦理电影wwwqiuxia6commqiuxia6com 怡春院分站 丝袜超短裙露脸迅雷下载 色制服电影院 97超碰好吊色男人 yy6080理论在线宅男日韩福利大全 大嫂丝袜 500人群交手机在线 5sav 偷拍熟女吧 口述我和妹妹的欲望 50p电脑版 wwwavtttcon 3p3com 伦理无码片在线看 欧美成人电影图片岛国性爱伦理电影 先锋影音AV成人欧美 我爱好色 淫电影网 WWW19MMCOM 玛丽罗斯3d同人动画h在线看 动漫女孩裸体 超级丝袜美腿乱伦 1919gogo欣赏 大色逼淫色 www就是撸 激情文学网好骚 A级黄片免费 xedd5com 国内的b是黑的 快播美国成年人片黄 av高跟丝袜视频 上原保奈美巨乳女教师在线观看 校园春色都市激情fefegancom 偷窥自拍XXOO 搜索看马操美女 人本女优视频 日日吧淫淫 人妻巨乳影院 美国女子性爱学校 大肥屁股重口味 啪啪啪啊啊啊不要 操碰 japanfreevideoshome国产 亚州淫荡老熟女人体 伦奸毛片免费在线看 天天影视se 樱桃做爱视频 亚卅av在线视频 x奸小说下载 亚洲色图图片在线 217av天堂网 东方在线撸撸-百度 幼幼丝袜集 灰姑娘的姐姐 青青草在线视频观看对华 86papa路con 亚洲1AV 综合图片2区亚洲 美国美女大逼电影 010插插av成人网站 www色comwww821kxwcom 播乐子成人网免费视频在线观看 大炮撸在线影院 ,www4KkKcom 野花鲁最近30部 wwwCC213wapwww2233ww2download 三客优最新地址 母亲让儿子爽的无码视频 全国黄色片子 欧美色图美国十次 超碰在线直播 性感妖娆操 亚洲肉感熟女色图 a片A毛片管看视频 8vaa褋芯屑 333kk 川岛和津实视频 在线母子乱伦对白 妹妹肥逼五月 亚洲美女自拍 老婆在我面前小说 韩国空姐堪比情趣内衣 干小姐综合 淫妻色五月 添骚穴 WM62COM 23456影视播放器 成人午夜剧场 尼姑福利网 AV区亚洲AV欧美AV512qucomwwwc5508com 经典欧美骚妇 震动棒露出 日韩丝袜美臀巨乳在线 av无限吧看 就去干少妇 色艺无间正面是哪集 校园春色我和老师做爱 漫画夜色 天海丽白色吊带 黄色淫荡性虐小说 午夜高清播放器 文20岁女性荫道口图片 热国产热无码热有码 2015小明发布看看算你色 百度云播影视 美女肏屄屄乱轮小说 家族舔阴AV影片 邪恶在线av有码 父女之交 关于处女破处的三级片 极品护士91在线 欧美虐待女人视频的网站 享受老太太的丝袜 aaazhibuo 8dfvodcom成人 真实自拍足交 群交男女猛插逼 妓女爱爱动态 lin35com是什么网站 abp159 亚洲色图偷拍自拍乱伦熟女抠逼自慰 朝国三级篇 淫三国幻想 免费的av小电影网站 日本阿v视频免费按摩师 av750c0m 黄色片操一下 巨乳少女车震在线观看 操逼 免费 囗述情感一乱伦岳母和女婿 WWW_FAMITSU_COM 偷拍中国少妇在公车被操视频 花也真衣论理电影 大鸡鸡插p洞 新片欧美十八岁美少 进击的巨人神thunderftp 西方美女15p 深圳哪里易找到老女人玩视频 在线成人有声小说 365rrr 女尿图片 我和淫荡的小姨做爱 � 做爱技术体照 淫妇性爱 大学生私拍b 第四射狠狠射小说 色中色成人av社区 和小姨子乱伦肛交 wwwppp62com 俄罗斯巨乳人体艺术 骚逼阿娇 汤芳人体图片大胆 大胆人体艺术bb私处 性感大胸骚货 哪个网站幼女的片多 日本美女本子把 色 五月天 婷婷 快播 美女 美穴艺术 色百合电影导航 大鸡巴用力 孙悟空操美少女战士 狠狠撸美女手掰穴图片 古代女子与兽类交 沙耶香套图 激情成人网区 暴风影音av播放 动漫女孩怎么插第3个 mmmpp44 黑木麻衣无码ed2k 淫荡学姐少妇 乱伦操少女屄 高中性爱故事 骚妹妹爱爱图网 韩国模特剪长发 大鸡巴把我逼日了 中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片中国张柏芝做爱片 大胆女人下体艺术图片 789sss 影音先锋在线国内情侣野外性事自拍普通话对白 群撸图库 闪现君打阿乐 ady 小说 插入表妹嫩穴小说 推荐成人资源 网络播放器 成人台 149大胆人体艺术 大屌图片 骚美女成人av 春暖花开春色性吧 女亭婷五月 我上了同桌的姐姐 恋夜秀场主播自慰视频 yzppp 屄茎 操屄女图 美女鲍鱼大特写 淫乱的日本人妻山口玲子 偷拍射精图 性感美女人体艺木图片 种马小说完本 免费电影院 骑士福利导航导航网站 骚老婆足交 国产性爱一级电影 欧美免费成人花花性都 欧美大肥妞性爱视频 家庭乱伦网站快播 偷拍自拍国产毛片 金发美女也用大吊来开包 缔D杏那 yentiyishu人体艺术ytys WWWUUKKMCOM 女人露奶 � 苍井空露逼 老荡妇高跟丝袜足交 偷偷和女友的朋友做爱迅雷 做爱七十二尺 朱丹人体合成 麻腾由纪妃 帅哥撸播种子图 鸡巴插逼动态图片 羙国十次啦中文 WWW137AVCOM 神斗片欧美版华语 有气质女人人休艺术 由美老师放屁电影 欧美女人肉肏图片 白虎种子快播 国产自拍90后女孩 美女在床上疯狂嫩b 饭岛爱最后之作 幼幼强奸摸奶 色97成人动漫 两性性爱打鸡巴插逼 新视觉影院4080青苹果影院 嗯好爽插死我了 阴口艺术照 李宗瑞电影qvod38 爆操舅母 亚洲色图七七影院 被大鸡巴操菊花 怡红院肿么了 成人极品影院删除 欧美性爱大图色图强奸乱 欧美女子与狗随便性交 苍井空的bt种子无码 熟女乱伦长篇小说 大色虫 兽交幼女影音先锋播放 44aad be0ca93900121f9b 先锋天耗ばさ无码 欧毛毛女三级黄色片图 干女人黑木耳照 日本美女少妇嫩逼人体艺术 sesechangchang 色屄屄网 久久撸app下载 色图色噜 美女鸡巴大奶 好吊日在线视频在线观看 透明丝袜脚偷拍自拍 中山怡红院菜单 wcwwwcom下载 骑嫂子 亚洲大色妣 成人故事365ahnet 丝袜家庭教mp4 幼交肛交 妹妹撸撸大妈 日本毛爽 caoprom超碰在email 关于中国古代偷窥的黄片 第一会所老熟女下载 wwwhuangsecome 狼人干综合新地址HD播放 变态儿子强奸乱伦图 强奸电影名字 2wwwer37com 日本毛片基地一亚洲AVmzddcxcn 暗黑圣经仙桃影院 37tpcocn 持月真由xfplay 好吊日在线视频三级网 我爱背入李丽珍 电影师傅床戏在线观看 96插妹妹sexsex88com 豪放家庭在线播放 桃花宝典极夜著豆瓜网 安卓系统播放神器 美美网丝袜诱惑 人人干全免费视频xulawyercn av无插件一本道 全国色五月 操逼电影小说网 good在线wwwyuyuelvcom www18avmmd 撸波波影视无插件 伊人幼女成人电影 会看射的图片 小明插看看 全裸美女扒开粉嫩b 国人自拍性交网站 萝莉白丝足交本子 七草ちとせ巨乳视频 摇摇晃晃的成人电影 兰桂坊成社人区小说www68kqcom 舔阴论坛 久撸客一撸客色国内外成人激情在线 明星门 欧美大胆嫩肉穴爽大片 www牛逼插 性吧星云 少妇性奴的屁眼 人体艺术大胆mscbaidu1imgcn 最新久久色色成人版 l女同在线 小泽玛利亚高潮图片搜索 女性裸b图 肛交bt种子 最热门有声小说 人间添春色 春色猜谜字 樱井莉亚钢管舞视频 小泽玛利亚直美6p 能用的h网 还能看的h网 bl动漫h网 开心五月激 东京热401 男色女色第四色酒色网 怎么下载黄色小说 黄色小说小栽 和谐图城 乐乐影院 色哥导航 特色导航 依依社区 爱窝窝在线 色狼谷成人 91porn 包要你射电影 色色3A丝袜 丝袜妹妹淫网 爱色导航(荐) 好男人激情影院 坏哥哥 第七色 色久久 人格分裂 急先锋 撸撸射中文网 第一会所综合社区 91影院老师机 东方成人激情 怼莪影院吹潮 老鸭窝伊人无码不卡无码一本道 av女柳晶电影 91天生爱风流作品 深爱激情小说私房婷婷网 擼奶av 567pao 里番3d一家人野外 上原在线电影 水岛津实透明丝袜 1314酒色 网旧网俺也去 0855影院 在线无码私人影院 搜索 国产自拍 神马dy888午夜伦理达达兔 农民工黄晓婷 日韩裸体黑丝御姐 屈臣氏的燕窝面膜怎么样つぼみ晶エリーの早漏チ○ポ强化合宿 老熟女人性视频 影音先锋 三上悠亚ol 妹妹影院福利片 hhhhhhhhsxo 午夜天堂热的国产 强奸剧场 全裸香蕉视频无码 亚欧伦理视频 秋霞为什么给封了 日本在线视频空天使 日韩成人aⅴ在线 日本日屌日屄导航视频 在线福利视频 日本推油无码av magnet 在线免费视频 樱井梨吮东 日本一本道在线无码DVD 日本性感诱惑美女做爱阴道流水视频 日本一级av 汤姆avtom在线视频 台湾佬中文娱乐线20 阿v播播下载 橙色影院 奴隶少女护士cg视频 汤姆在线影院无码 偷拍宾馆 业面紧急生级访问 色和尚有线 厕所偷拍一族 av女l 公交色狼优酷视频 裸体视频AV 人与兽肉肉网 董美香ol 花井美纱链接 magnet 西瓜影音 亚洲 自拍 日韩女优欧美激情偷拍自拍 亚洲成年人免费视频 荷兰免费成人电影 深喉呕吐XXⅩX 操石榴在线视频 天天色成人免费视频 314hu四虎 涩久免费视频在线观看 成人电影迅雷下载 能看见整个奶子的香蕉影院 水菜丽百度影音 gwaz079百度云 噜死你们资源站 主播走光视频合集迅雷下载 thumbzilla jappen 精品Av 古川伊织star598在线 假面女皇vip在线视频播放 国产自拍迷情校园 啪啪啪公寓漫画 日本阿AV 黄色手机电影 欧美在线Av影院 华裔电击女神91在线 亚洲欧美专区 1日本1000部免费视频 开放90后 波多野结衣 东方 影院av 页面升级紧急访问每天正常更新 4438Xchengeren 老炮色 a k福利电影 色欲影视色天天视频 高老庄aV 259LUXU-683 magnet 手机在线电影 国产区 欧美激情人人操网 国产 偷拍 直播 日韩 国内外激情在线视频网给 站长统计一本道人妻 光棍影院被封 紫竹铃取汁 ftp 狂插空姐嫩 xfplay 丈夫面前 穿靴子伪街 XXOO视频在线免费 大香蕉道久在线播放 电棒漏电嗨过头 充气娃能看下毛和洞吗 夫妻牲交 福利云点墦 yukun瑟妃 疯狂交换女友 国产自拍26页 腐女资源 百度云 日本DVD高清无码视频 偷拍,自拍AV伦理电影 A片小视频福利站。 大奶肥婆自拍偷拍图片 交配伊甸园 超碰在线视频自拍偷拍国产 小热巴91大神 rctd 045 类似于A片 超美大奶大学生美女直播被男友操 男友问 你的衣服怎么脱掉的 亚洲女与黑人群交视频一 在线黄涩 木内美保步兵番号 鸡巴插入欧美美女的b舒服 激情在线国产自拍日韩欧美 国语福利小视频在线观看 作爱小视颍 潮喷合集丝袜无码mp4 做爱的无码高清视频 牛牛精品 伊aⅤ在线观看 savk12 哥哥搞在线播放 在线电一本道影 一级谍片 250pp亚洲情艺中心,88 欧美一本道九色在线一 wwwseavbacom色av吧 cos美女在线 欧美17,18ⅹⅹⅹ视频 自拍嫩逼 小电影在线观看网站 筱田优 贼 水电工 5358x视频 日本69式视频有码 b雪福利导航 韩国女主播19tvclub在线 操逼清晰视频 丝袜美女国产视频网址导航 水菜丽颜射房间 台湾妹中文娱乐网 风吟岛视频 口交 伦理 日本熟妇色五十路免费视频 A级片互舔 川村真矢Av在线观看 亚洲日韩av 色和尚国产自拍 sea8 mp4 aV天堂2018手机在线 免费版国产偷拍a在线播放 狠狠 婷婷 丁香 小视频福利在线观看平台 思妍白衣小仙女被邻居强上 萝莉自拍有水 4484新视觉 永久发布页 977成人影视在线观看 小清新影院在线观 小鸟酱后丝后入百度云 旋风魅影四级 香蕉影院小黄片免费看 性爱直播磁力链接 小骚逼第一色影院 性交流的视频 小雪小视频bd 小视频TV禁看视频 迷奸AV在线看 nba直播 任你在干线 汤姆影院在线视频国产 624u在线播放 成人 一级a做爰片就在线看狐狸视频 小香蕉AV视频 www182、com 腿模简小育 学生做爱视频 秘密搜查官 快播 成人福利网午夜 一级黄色夫妻录像片 直接看的gav久久播放器 国产自拍400首页 sm老爹影院 谁知道隔壁老王网址在线 综合网 123西瓜影音 米奇丁香 人人澡人人漠大学生 色久悠 夜色视频你今天寂寞了吗? 菲菲影视城美国 被抄的影院 变态另类 欧美 成人 国产偷拍自拍在线小说 不用下载安装就能看的吃男人鸡巴视频 插屄视频 大贯杏里播放 wwwhhh50 233若菜奈央 伦理片天海翼秘密搜查官 大香蕉在线万色屋视频 那种漫画小说你懂的 祥仔电影合集一区 那里可以看澳门皇冠酒店a片 色自啪 亚洲aV电影天堂 谷露影院ar toupaizaixian sexbj。com 毕业生 zaixian mianfei 朝桐光视频 成人短视频在线直接观看 陈美霖 沈阳音乐学院 导航女 www26yjjcom 1大尺度视频 开平虐女视频 菅野雪松协和影视在线视频 华人play在线视频bbb 鸡吧操屄视频 多啪啪免费视频 悠草影院 金兰策划网 (969) 橘佑金短视频 国内一极刺激自拍片 日本制服番号大全magnet 成人动漫母系 电脑怎么清理内存 黄色福利1000 dy88午夜 偷拍中学生洗澡磁力链接 花椒相机福利美女视频 站长推荐磁力下载 mp4 三洞轮流插视频 玉兔miki热舞视频 夜生活小视频 爆乳人妖小视频 国内网红主播自拍福利迅雷下载 不用app的裸裸体美女操逼视频 变态SM影片在线观看 草溜影院元气吧 - 百度 - 百度 波推全套视频 国产双飞集合ftp 日本在线AV网 笔国毛片 神马影院女主播是我的邻居 影音资源 激情乱伦电影 799pao 亚洲第一色第一影院 av视频大香蕉 老梁故事汇希斯莱杰 水中人体磁力链接 下载 大香蕉黄片免费看 济南谭崔 避开屏蔽的岛a片 草破福利 要看大鸡巴操小骚逼的人的视频 黑丝少妇影音先锋 欧美巨乳熟女磁力链接 美国黄网站色大全 伦蕉在线久播 极品女厕沟 激情五月bd韩国电影 混血美女自摸和男友激情啪啪自拍诱人呻吟福利视频 人人摸人人妻做人人看 44kknn 娸娸原网 伊人欧美 恋夜影院视频列表安卓青青 57k影院 如果电话亭 avi 插爆骚女精品自拍 青青草在线免费视频1769TV 令人惹火的邻家美眉 影音先锋 真人妹子被捅动态图 男人女人做完爱视频15 表姐合租两人共处一室晚上她竟爬上了我的床 性爱教学视频 北条麻妃bd在线播放版 国产老师和师生 magnet wwwcctv1024 女神自慰 ftp 女同性恋做激情视频 欧美大胆露阴视频 欧美无码影视 好女色在线观看 后入肥臀18p 百度影视屏福利 厕所超碰视频 强奸mp magnet 欧美妹aⅴ免费线上看 2016年妞干网视频 5手机在线福利 超在线最视频 800av:cOm magnet 欧美性爱免播放器在线播放 91大款肥汤的性感美乳90后邻家美眉趴着窗台后入啪啪 秋霞日本毛片网站 cheng ren 在线视频 上原亚衣肛门无码解禁影音先锋 美脚家庭教师在线播放 尤酷伦理片 熟女性生活视频在线观看 欧美av在线播放喷潮 194avav 凤凰AV成人 - 百度 kbb9999 AV片AV在线AV无码 爱爱视频高清免费观看 黄色男女操b视频 观看 18AV清纯视频在线播放平台 成人性爱视频久久操 女性真人生殖系统双性人视频 下身插入b射精视频 明星潜规测视频 mp4 免賛a片直播绪 国内 自己 偷拍 在线 国内真实偷拍 手机在线 国产主播户外勾在线 三桥杏奈高清无码迅雷下载 2五福电影院凸凹频频 男主拿鱼打女主,高宝宝 色哥午夜影院 川村まや痴汉 草溜影院费全过程免费 淫小弟影院在线视频 laohantuiche 啪啪啪喷潮XXOO视频 青娱乐成人国产 蓝沢润 一本道 亚洲青涩中文欧美 神马影院线理论 米娅卡莉法的av 在线福利65535 欧美粉色在线 欧美性受群交视频1在线播放 极品喷奶熟妇在线播放 变态另类无码福利影院92 天津小姐被偷拍 磁力下载 台湾三级电髟全部 丝袜美腿偷拍自拍 偷拍女生性行为图 妻子的乱伦 白虎少妇 肏婶骚屄 外国大妈会阴照片 美少女操屄图片 妹妹自慰11p 操老熟女的b 361美女人体 360电影院樱桃 爱色妹妹亚洲色图 性交卖淫姿势高清图片一级 欧美一黑对二白 大色网无毛一线天 射小妹网站 寂寞穴 西西人体模特苍井空 操的大白逼吧 骚穴让我操 拉好友干女朋友3p